Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The 14th signing for this quarter

Considering PTSC reports their investment in affiliated company PTSC as a simple three line Revenue-Expenses=Net Revenue, how do you think under the scenarios you mention can be illucidated in PTSC's income statement and balance sheet. Will they get into that much detail, and/or are they required to?

Share
New Message
Please login to post a reply